Clinical Trial Update: Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions

View source ↗

Summary

A clinical trial update describes evaluating 68Ga-Pentixafor PET/MR for detecting lesions in non-Hodgkin lymphoma and multiple myeloma; the study status is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• 68Ga-Pentixafor PET/MR (pentixafor labeled with Gallium-68)

Snippet

Sponsor: Shanghai East Hospital | Conditions: Non Hodgkin's Lymphoma, Multiple Myeloma (MM) | Status: NOT_YET_RECRUITING